Original document(73 pages)  中文版
    Described are novel compounds with neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity of the general formula (I), wherein the substituents R<1>, R<2> , R<3> and R<4> have the meanings given in the description and also medicaments containing these compounds, in particular medicaments suitable for treating or preventing cardiovascular diseases, sexual dysfunction and/or adverse conditions associated with apoptosis.
Application Number
申请号
200480027747 Application Date
申请日
2004.09.23
Title 名称 Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compou
Publication Number
公开号
1856501 Publication Date
公开日
2006.11.01
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07K5/06,A61K38/05,A61P9/12
Applicant(s) Name
申请人
Solvay Pharm GmbH
Address 地址
Inventor(s) Name 发明人 Hoeltje Dagmar, Fischer Yvan, Ziegler Dieter, Weske Michael, Michaelis Kathrin, Karimi-Nejad Yasmin, Messinger Josef, Pahl Axel, Hoefer Constanze, Ikonomidou Hrissanthi
Attorney & Agent 代理人 wu yihua
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.